Today: 7 February 2026
Subscribe

Coherent Corp (COHR) Stock Soars 62% YTD: Latest News, Analyst Forecasts and AI-Fueled Outlook as of December 2, 2025

Coherent Corp (COHR) Stock Soars 62% YTD: Latest News, Analyst Forecasts and AI-Fueled Outlook as of December 2, 2025

Published: December 2, 2025 — For informational purposes only; not investment advice. Coherent Corp Stock Today: Price Snapshot and Momentum Coherent Corp (NYSE: COHR), a leading photonics and materials company, continues to ride one of the strongest rallies in the semiconductor-and-optics space in 2025. Coherent operates across three main segments — Networking, Materials and Lasers — with the Networking segment (optical transceivers and related components) contributing the largest share of revenue. Coherent Inc+1 These businesses position COHR at the intersection of several secular trends: AI data centers, co‑packaged optics, silicon carbide for EVs, and advanced industrial laser processing. What’s New
2 December 2025
·
Dell Technologies Stock Jumps on $6.25 Billion Dell Family Gift and AI Server Boom – Latest News, Forecasts and Analysis (December 2, 2025)

Dell Technologies Stock Jumps on $6.25 Billion Dell Family Gift and AI Server Boom – Latest News, Forecasts and Analysis (December 2, 2025)

Dell Technologies Inc. (NYSE: DELL) is back in the spotlight on December 2, 2025, as markets cheer both a historic $6.25 billion philanthropic pledge by founder Michael Dell and his wife Susan and the company’s fast‑growing AI server business. Dell Technologies stock today: price, move and trading signals As of Tuesday, December 2, 2025, Dell Technologies stock is trading around $135.55, up roughly 2.6% on the day. Intraday, shares have traded between about $132 and $138, with volume approaching 4 million shares, indicating elevated investor interest compared with recent sessions. Options data show that “whale” traders have been unusually active
2 December 2025
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts

Thermo Fisher Scientific Inc. (NYSE: TMO) is ending 2025 in the spotlight. As of Tuesday, December 2, 2025, Thermo Fisher Scientific stock is trading around $580 per share, slightly lower on the day but still near the top of its 52‑week range of roughly $385 to $611. Thermo Fisher Scientific Investors are digesting a dense mix of developments: a €2.1 billion euro‑denominated bond offering, a $5 billion share repurchase authorization, fresh insider share‑sale filings, an HSBC price target hike to $670, and a strong year of earnings and acquisitions capped by a growing push into AI and clinical data. TechStock²+5Thermo
2 December 2025
·
Goldman Sachs (GS) Stock on December 2, 2025: Dividend Payout, $2 Billion ETF Deal and 2026 Outlook

Goldman Sachs (GS) Stock on December 2, 2025: Dividend Payout, $2 Billion ETF Deal and 2026 Outlook

Goldman Sachs Group, Inc. (NYSE: GS) is trading just below its record highs as of December 2, 2025, with investors digesting a fresh $4.00 dividend, a $2 billion ETF acquisition, and a lively debate over whether the stock is now fairly valued or stretched. StockAnalysis Below is a deep dive into today’s key news, forecasts and analyses around Goldman Sachs stock and what they may mean for investors. Key Takeaways for GS Stock Today Goldman Sachs Stock Today: Price, Range and Momentum Goldman Sachs stock is trading around $815 per share in today’s session, after opening slightly above $812 and
2 December 2025
··
Uber Stock (NYSE: UBER) on December 2, 2025: Earnings Power, Institutional Buying and Robotaxis Drive the 2026 Outlook

Uber Stock (NYSE: UBER) on December 2, 2025: Earnings Power, Institutional Buying and Robotaxis Drive the 2026 Outlook

Uber Technologies, Inc. (NYSE: UBER) is trading around $87–88 per share on December 2, 2025, giving the ride‑hailing and delivery giant a market capitalization of roughly $180 billion. The stock sits below its recent 52‑week high of about $102, but well above its low near $59, after a powerful multi‑year recovery and a profitable business model finally taking hold. StockAnalysis+1 Investors today are digesting three big storylines at once: Below is a detailed, news‑driven snapshot of Uber stock as of December 2, 2025, including today’s headlines, recent earnings, analyst forecasts, valuation views and the key risks to watch. Uber Stock
2 December 2025
···
Chevron Stock (CVX) Today: HSBC Upgrade, Nigeria Deal, Drone Risk and 2030 Cash‑Flow Plan

Chevron Stock (CVX) Today: HSBC Upgrade, Nigeria Deal, Drone Risk and 2030 Cash‑Flow Plan

Chevron Corporation (NYSE: CVX) is back on the radar for global investors on December 2, 2025, as markets digest a major analyst upgrade, fresh offshore exploration deals in Nigeria, and new geopolitical risk after a drone attack on a key export pipeline — all against the backdrop of Chevron’s ambitious 2030 cash‑flow growth plan. This article pulls together the most important news, forecasts and analysis as of December 2, 2025, to help you understand where Chevron stock stands right now and what could drive CVX next. Note: This article is informational and not investment advice. Always do your own research
2 December 2025
·
Exxon Mobil (XOM) Stock on December 2, 2025: West Qurna Deal Talks, Hydrogen Pivot and 2026 Price Targets

Exxon Mobil (XOM) Stock on December 2, 2025: West Qurna Deal Talks, Hydrogen Pivot and 2026 Price Targets

As of midday trading on December 2, 2025, Exxon Mobil Corporation (NYSE: XOM) is trading around $115 per share, down roughly 1% on the day and sitting a few percent below its 52‑week high of about $120.81. Over the past year, the stock has been roughly flat to slightly negative in price terms, even as it has delivered a high‑single‑digit total return year‑to‑date, thanks largely to its dividend. Investing.com+1 Yet under the surface, the story is anything but quiet. On December 2, Reuters reported that Exxon has approached Iraq about buying Russian company Lukoil’s majority stake in the giant West
2 December 2025
Oklo Stock (OKLO) on December 2, 2025: Bubble, Breakthrough – or Both? Latest News, Forecasts & Analysis

Oklo Stock (OKLO) on December 2, 2025: Bubble, Breakthrough – or Both? Latest News, Forecasts & Analysis

As of December 2, 2025, Oklo Inc. (NYSE: OKLO) sits at the center of two of the market’s biggest themes: advanced nuclear power and the surging energy needs of AI data centers. The stock is still up well over 300% year to date, yet has also lost more than half of its value since its autumn peak, making it one of the most volatile names in the utilities and clean‑energy space. StockAnalysis+1 This article pulls together the most important news, analyst forecasts, and expert commentary available up to December 2, 2025, including fresh pieces from MarketBeat, InvestorsObserver, Forbes, Barron’s, Reuters,
2 December 2025
Western Digital (WDC) Stock: Citi Lifts Target to $200 as AI Storage Boom Collides With Rich Valuation – December 2, 2025 Update

Western Digital (WDC) Stock: Citi Lifts Target to $200 as AI Storage Boom Collides With Rich Valuation – December 2, 2025 Update

Published: December 2, 2025 – For informational purposes only, not investment advice. Key Takeaways Western Digital Stock Today: Price Action and Performance Snapshot As of the latest trading data on December 2, 2025, Western Digital stock changes hands around $160.07, after swinging between $156.46 and $169.59 intraday on solid volume. Key trading metrics: In total‑return terms, Western Digital has been a monster: Recent coverage by Barron’s notes that Western Digital’s ~269% gain in 2025 leads the entire S&P 500, outpacing even high‑profile AI names. Barron’s+1 How 2025 Reshaped Western Digital: From Conglomerate to AI HDD Pure Play Spin‑off of SanDisk
2 December 2025
··
Bank of America Stock (BAC) Today: Buffett Trims Stake as Crypto Pivot and 2026 Outlook Shape the Bull Case – December 2, 2025

Bank of America Stock (BAC) Today: Buffett Trims Stake as Crypto Pivot and 2026 Outlook Shape the Bull Case – December 2, 2025

Bank of America Corporation (NYSE: BAC) is trading near record territory on December 2, 2025, even as Warren Buffett continues to trim his long‑held stake and Wall Street prices in a slower‑growth equity market for 2026. The latest headlines around Bank of America stock center on a bullish new macro forecast from BofA Global Research, a high‑profile shift into crypto for wealth clients, fresh analyst upgrades, and a technical setup that traders say could precede a breakout. ChartMill+3Bank of America+3Parameter+3 Below is a detailed look at the most important news, forecasts, and analysis for BAC as of December 2, 2025.
2 December 2025
Applied Digital (APLD) Stock Jumps on Corintis Deal: Fresh AI Data‑Center Milestones and 2026–2030 Forecasts Explained

Applied Digital (APLD) Stock Jumps on Corintis Deal: Fresh AI Data‑Center Milestones and 2026–2030 Forecasts Explained

Published: December 2, 2025 Applied Digital Corporation (NASDAQ: APLD) is back in the spotlight after announcing a strategic $25 million investment in chip‑cooling specialist Corintis — a move that reinforces its ambition to become a key infrastructure provider for the AI boom. On the same backdrop of multi‑billion‑dollar hyperscaler leases and rapid campus build‑outs, Wall Street forecasts, AI‑driven models, and retail sentiment are converging on one question: how much further can APLD stock run? As of late trading on December 2, 2025, Applied Digital shares are changing hands around $29.8 per share, valuing the company at roughly $8–8.5 billion. That’s
2 December 2025
···
MongoDB (MDB) Stock Soars Over 20% After Blowout Q3 Earnings and AI Momentum – Latest News, Analyst Upgrades & 2026–2027 Outlook

MongoDB (MDB) Stock Soars Over 20% After Blowout Q3 Earnings and AI Momentum – Latest News, Analyst Upgrades & 2026–2027 Outlook

Updated: December 2, 2025 Key Takeaways Below is a deep dive into the latest numbers, the AI narrative, Wall Street sentiment, and key risks around MongoDB stock. Note: This article is for informational and educational purposes only and is not investment advice. MongoDB Stock Today: Huge Post‑Earnings Move As of Tuesday afternoon, December 2, 2025, MongoDB shares trade around $408, up roughly 24–25% on the day with intraday trading between about $400 and $419. A few context points: In short, MDB has gone from a strong 2025 performer to one of the day’s standout tech winners after earnings, with trading
2 December 2025
··
Marvell Technology (MRVL) Stock: Celestial AI Deal Rumors, Q3 Earnings Preview and Analyst Targets as of December 2, 2025

Marvell Technology (MRVL) Stock: Celestial AI Deal Rumors, Q3 Earnings Preview and Analyst Targets as of December 2, 2025

Marvell Technology, Inc. (NASDAQ: MRVL) is back in the spotlight. The AI‑focused chipmaker is trading around $93 per share on December 2, 2025, up a little over 2% intraday, as investors digest multi‑billion‑dollar M&A chatter, a high‑growth earnings setup, and fresh analyst upgrades. GuruFocus A Reuters report says Marvell is in advanced talks to acquire photonics startup Celestial AI in a cash‑and‑stock deal that could be worth more than $5 billion, potentially as soon as this week. Reuters At the same time, Wall Street is gearing up for Marvell’s Q3 fiscal 2026 results, scheduled for release after today’s close, followed
2 December 2025
·
Johnson & Johnson (JNJ) Stock Near Record Highs: New EU Drug Approval, Oncology Deal and 2026 Outlook

Johnson & Johnson (JNJ) Stock Near Record Highs: New EU Drug Approval, Oncology Deal and 2026 Outlook

As of December 2, 2025, Johnson & Johnson (NYSE: JNJ) is trading just below all‑time highs, supported by a powerful 2025 rally, a fresh European Union drug approval, a new $3.05 billion oncology acquisition, and a planned spin‑off of its orthopaedics business. Together, these moves are reshaping the investment case for JNJ as it heads into 2026. Below is a news-style rundown of the latest price action, fundamentals, pipeline news, Wall Street forecasts and key risks that matter for Johnson & Johnson stock today. JNJ stock today: Price, market cap and performance in 2025 On performance, JNJ has easily outpaced
2 December 2025
··
Applied Materials (AMAT) Stock Hits New Highs as Wall Street Lifts Targets on AI Boom – December 2, 2025 Outlook

Applied Materials (AMAT) Stock Hits New Highs as Wall Street Lifts Targets on AI Boom – December 2, 2025 Outlook

Applied Materials, Inc. (NASDAQ: AMAT) continues to ride the AI infrastructure wave, with the stock pushing to fresh 52‑week highs around $259–$261 on December 2, 2025. That’s roughly a 41% gain over the past year, with a new high near $261.71 and a 52‑week range of about $123.74–$261.71. Investing.com+1 At the same time, analysts are busily lifting price targets, new institutional money is flowing into the name, and the company is digesting export controls and layoffs that could shave hundreds of millions off 2026 revenue. Reuters+2Reuters+2 This article pulls together the latest news, forecasts, and expert analyses as of December
2 December 2025
··
Iren (IREN) Stock on December 2, 2025: Microsoft’s $9.7B AI Deal, $2B Notes Offering and 2026 Price Targets Explained

Iren (IREN) Stock on December 2, 2025: Microsoft’s $9.7B AI Deal, $2B Notes Offering and 2026 Price Targets Explained

Date: December 2, 2025Language: English | Ticker: IREN (Nasdaq) IREN stock is under pressure after a fresh $2 billion convertible notes and equity offering, even as a $9.7 billion Microsoft AI cloud deal, explosive earnings and bullish Wall Street price targets fuel a high‑risk, high‑reward story heading into 2026. Note: This article focuses on IREN Limited (NASDAQ: IREN), the Australian‑founded, renewable‑powered data center and former bitcoin miner, not Italian utility Iren S.p.A. (BIT: IRE / FRA: TZ8). 1. IREN stock today: price, performance and volatility As of trading on December 2, 2025, IREN Ltd (IREN) is changing hands in the mid‑$40s, around $46–47 per share, down from a prior close
2 December 2025
·
Pfizer (PFE) Stock on December 2, 2025: Price, Metsera Deal, New FDA Risks and 2026 Outlook

Pfizer (PFE) Stock on December 2, 2025: Price, Metsera Deal, New FDA Risks and 2026 Outlook

As of late trading on Tuesday, December 2, 2025, Pfizer (NYSE: PFE) shares change hands around $25.10, down roughly 0.7% on the day and sitting in the middle of their 52‑week range of $20.92–$27.69.Yahoo Finance+1 The stock carries a dividend yield close to 7%, reflecting a generous payout but also lingering skepticism about the pharma giant’s growth post‑COVID.Pfizer+1 Today’s price is being shaped by a dense mix of headlines: a fresh FDA push to tighten vaccine oversight, a legal setback for Pfizer’s Seagen unit, the completion of a $10 billion obesity-drug acquisition, and earlier this quarter, upgraded 2025 profit guidance and new oncology approvals.Pfizer+4Investopedia+4Reuters+4 Below is
2 December 2025
·
Nebius Stock (NBIS) on December 2, 2025: AI Mega‑Deals, 250% Rally and What Wall Street Expects Next

Nebius Stock (NBIS) on December 2, 2025: AI Mega‑Deals, 250% Rally and What Wall Street Expects Next

Nebius Group N.V. (NASDAQ: NBIS) is back in the spotlight on December 2, 2025, as the AI‑infrastructure stock trades around the $100 mark after a year of explosive gains, violent pullbacks, and game‑changing cloud contracts with Microsoft and Meta Platforms.Google+1 Fresh coverage today from Motley Fool, InvestorsObserver, Benzinga and Simply Wall St is sharpening the debate: is Nebius stock still an under‑appreciated AI infrastructure play, or a high‑beta name priced for perfection? Nebius stock today: price, performance and volatility As of midday on December 2, 2025, Nebius stock is trading just under $100 per share, with intraday quotes in roughly the $99–102 range.Google+1 Key snapshot metrics: In other words, Nebius stock has already
2 December 2025
··
Nvidia Stock (NVDA) on December 2, 2025: Price Action, New AI Deals and 2026–2030 Stock Forecasts

Nvidia Stock (NVDA) on December 2, 2025: Price Action, New AI Deals and 2026–2030 Stock Forecasts

Nvidia’s stock remains at the center of the AI trade as of Tuesday, December 2, 2025. After another blowout earnings report and a fresh $2 billion strategic bet on Synopsys, the chipmaker is still posting eye‑watering growth — even as investors debate whether its $4+ trillion valuation leaves more upside or sets up an AI bubble risk. NVIDIA Newsroom+2Finviz+2 Below is a news-style roundup of the key Nvidia (NVDA) developments, forecasts and analyses as of December 2, 2025, based on major financial news outlets, company filings and analyst data. Nvidia stock price today: still elevated, but off its peak At midday on
2 December 2025
··
Alphabet (GOOGL) Stock on December 2, 2025: Gemini 3, Buffett’s Bet and New $375 Price Targets

Alphabet (GOOGL) Stock on December 2, 2025: Gemini 3, Buffett’s Bet and New $375 Price Targets

Updated: December 2, 2025 – U.S. midday trading Alphabet (NASDAQ: GOOGL, GOOG) is trading around $315 today, near record highs, after a blistering AI‑driven run that has pushed its market value to roughly $3.8 trillion and cemented it among the three most valuable companies in the world.StockAnalysis+2StockAnalysis+2 The stock is up about 70% year to date, powered by three big storylines: At the same time, regulators on both sides of the Atlantic are still circling, and valuation multiples have climbed to levels where even bullish analysts are starting to talk about “premium pricing” and “overbought” conditions.TechStock²+3IG+3InsiderFinance+3 Below is a deep dive into where Alphabet stock stands today and what
2 December 2025
·
1 … 1,147 1,148 1,149 1,150 1,151 … 1,636

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop